halloween treat top read note rank
order buysid
top note octob includ idea note healthcar flow
thought futur hc stock perform list stock trade cash
pipelin valu analysi cash burn rate past year list compani
need cash soon primer gene therapy/edit addit highlight add
report team contain uniqu insights/differenti view
revisit
industri smid-cap strategi stock pick live oct
industri search safeti cheapest biotech pipelin oct
industri burn rate last year grow sep
industri gene tx/edit primer -- space compani oct
industri ep thought year-end oct
new kra colorect data esmo show promis yet convinc
esmo conf-cal better stivarga sep
industri conf call jefferi biotech theme thought oct
initi coverag deciphera buy view one
attract opportun oncolog like significantli
de-risk lead asset ripretinib gist digest tract cancer support
current ev potenti fda approv ripretinib sale
revenu start addit pipelin product current pt
offer meaning upsid potenti anticip steadi news flow clinic
 regulatori front recent announc addit ripretinib gist
show signific surviv benefit continu see no/minim regulatori risk
ripretinib gist high probabl success expand gist set
expect potenti interim data gist
mdco conduct doctor survey result suggest inclisiran consensu
aggress stock appear fulli valu inclisiran would split share
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
bempedo acid therefor cut
estimate st con annual also doc want
see cvot/safeti data prescrib lukewarm administ inclisiran
offic mdco follow payer survey doctor
survey note receiv feedback payer could drive inclisiran use result
indic inclisiran could face similar reimburs hurdl mab despit
medicar part payer would consid give unrestrict access
median price also two-third payer would requir step edit
bempedo acid
insid addit comment yang amin raycroft howerton
pleas see import disclosur inform page report
analyst investor research day reiter top-line
clinic data two lead program muscl biopsi dystrophin data
on-going ole dmd exon program suvodirsen mutant/tot
huntingtin htt protein level on-going huntington diseas program
detail htt assay measur provid continu view
high risk/reward opportun show dystrophin level dmd
compar mutant htt reduct spare wildtyp htt vs non-allel
specif competitor huntington diseas
 conduct wamd survey beovu approv gaug headwind
eylea doc continu view beovu favor believ safeti profil would
hinder prescrib rebat program could drive beovu uptak clear correl
two observ maintain eylea est slightli con
may add downsid survey accur investor focus
nsclc data present also late-break melanoma
cohort data co disclos data involv central
review respons data cohort howev co disclos whether plan
updat durat respons best case scenario would continu on-going median
durat impli better benefit therefor updat
highlight gene therapy/edit summit note w/
mention crsp provid info
space profil compani present takeaway presentations/
firesid chat summari panel discuss manufactur durabl safeti
regulatori aspect gene tx/edit highlight note detail
co confid bard omav w/ buy right back note
surprisingli robust omav fa data note follow shortli
deal also highlight note summar thought
pfe up-front partner akca-ion posit readthrough
note wrote investor mtg takeaway relat upcom aasld aha
data note highlight note detail thought relat lead
amgn kra data esmo note summari esmo data note
thought ahead initi data report tripl note
chri howerton key report
esmo report interim pivot muc data orr abnorm ae
consist w/ albeit short follow view data line w/ expect
maintain convict approv use set differenti
competitor ev held investor call w/ experienc pharma
ip lawyer view patent centerpiec gener korlym challeng
think ptab would institut repres upsid scenario
note ptab institut decis due decid upsiz
optic mix upsid could actual bode well
pleas see import disclosur inform page report
final result b/c reach max suggest pre-specifi power assumpt
work decis indic idmc believ work chanc
succeed see un-blind data first time
top note last week
pleas see import disclosur inform page report
tickertitled smid-cap strategi stock pick live ideasoctob safeti cheapest pipelin valueoctob burn rate last year grow need soon septemb tx/edit primer -- space compani attend summitoctob ep thought year-endoctob kra colorect data esmo show promis yet convinc streetseptemb gene therapy/edit summit panel discussionsoctob esmo conf-cal better stivarga sound like goal comboseptemb conf call jefferi theme thought year-endoctob oxb ln -- takeaway jefferi gene tx/edit summitoctob go gilead stock recentlyoctob nash hope phase ii combo data soon street expectationsoctob depress data week away thought recent price actionoctob read note buysid report highlightoctob -- takeaway jefferi gene tx/edit summitoctob look aasld titl releas moreoctob abstract friday nobel prize today valid roxa valu octob alz studi one w/ question make anoth binari wildcardoctob w/ co follow-up thought tidbit label launch buyoctob virtu octob renew hope could next holdoctob scorecard metric trend top perform year octob dinner conf call discuss potenti new renal drugsoctob continu suggest interest oral cv pill grow adoptionoctob octob month earli launch come buyoctob thing think go data look okay commerci oppti remain questionoctob posit ye last weekli catch-up minoctob late breaker cvot data call octob expect aasld data street still confus hbvoctob right major surpris look strateg movesoctob management confid phase data market opportunityoctob late-break note cont deeper declin marker hbv cure octob new cfo littl thought sign remain murki w/ key debt refin need holdoctob muc data esmo continu approv differentiatedseptemb meet rarx manag compel small-cap opportunityoctob w/ management thing could surpris upsid octob reimburs cf overhang remov thesi play buyoctob acquir achn modest size acquisit modest upsid successfuloctob buy de-risk lead asset pipelin upsid potentialseptemb acquir ucb move holdoctob call ip lawyer expect non-institut upsid scenario octob gene therapi data fatal neuro diseas continu show efficacyoctob call seri call w/ patent lawyer patent winoctob short interest market capoctob work w/ pt treat small up-siz maintain power octob research day reiter human efficaci data dmd hd blu buy favor risk/reward modest valuationseptemb equiti research
inform compani recommend
report pleas visit websit http //
javatar bluematrix com/sellside/disclosur action call
michael yee certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
biren amin certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
eun yang ph certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
mauri raycroft ph certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
chri howerton phd certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
act financi advisor review strateg option
jefferi llc act financi advisor nightstar therapeut plc announc acquisit biogen inc
jefferi llc act financi advisor kite pharma kite sale compani
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr axov gene therapi ltd
jefferi group llc make market secur adr biogen inc
jefferi group llc make market secur adr bellu health inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr corcept inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr esperion inc
jefferi group llc make market secur adr fibrogen inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr iovanc
pleas see import disclosur inform page report
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr medicin compani
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr ra inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr
jefferi group llc make market secur adr vertex pharmaceut incorpor
jefferi group llc make market secur adr
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
abeona inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
assembl bioscienc inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic axov gene therapi ltd
within past twelv month axov gene therapi ltd client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
axov gene therapi ltd one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
bellu health inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic bellu health inc
within past twelv month bellu health inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
bellu health inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
pleas see import disclosur inform page report
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
intellia inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month ltd client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
ltd one affili within past twelv month
